Liège, Belgium, February 8, 2023 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health has taken note of the statements made in the press release of its manufacturer of Estetrol.
At this time, Mithra does not wish to comment on these statements.
The payments in question are formally disputed and form part of an overall and complex factual situation.
These amounts have been provisioned and Mithra is taking appropriate measures to protect its interests and those of its stakeholders.
Mithra will inform the market in due time in accordance with its legal obligations inherent in its status as a listed company.
********
For more information, please contact:
Benoît Mathieu (IRO): +32 473 35 80 18 – [email protected]